Visual Biofeedback Through Transperineal Ultrasound During the Expulsive Phase of Labour to Improve Maternal Childbirth Satisfaction
NCT ID: NCT06847308
Last Updated: 2025-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
488 participants
INTERVENTIONAL
2025-03-01
2028-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Birth Ball and Perineal Massage on Perineal Pain, Perineal Trauma and Birth Satisfaction
NCT06935643
Determining the Effect of the ThetaHealing Meditation Method Given During the Antenatal Period on Labor Pain and Fear in Primiparous Women
NCT07267351
Online Web-Based Deep Relaxation Exercise Applied to Pregnant Women on Maternal Fetal Attachment and Pregnancy Perception
NCT06724874
The Effect of Exposure to an Informative Video on Maternal Anxiety
NCT04136301
Fear of Childbirth - Comparison of Two Treatments
NCT02306434
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention - VB with TPUS
Use of ultrasound for visual biofeedback
visual biofeedback through trans-perineal ultrasound
Trans-perineal ultrasound will be used to provide visual biofeedback during the active 2nd stage of labour, this for ten consecutive uterine contractions / pushing efforts
Control Group - standard of care
Control group that will receive standard of care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
visual biofeedback through trans-perineal ultrasound
Trans-perineal ultrasound will be used to provide visual biofeedback during the active 2nd stage of labour, this for ten consecutive uterine contractions / pushing efforts
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Term (37-42w) singleton gestations.
3. Vaginally nulliparous (no previous vaginal birth \> 20 weeks of gestation).
4. Fetus in cephalic presentation, without any major congenital or chromosomal anomalies.
5. Admitted to the delivery unit in labour, regardless of the onset (spontaneous or induced).
6. Epidural analgesia in situ.
7. Non-pathological CTG at the time of recruitment (2015 FIGO classification).
Exclusion Criteria
* History of severe PFDs/surgery (or any other condition affecting pelvic floor function/anatomy, besides pregnancy and delivery).
* Significant neurological disease e.g., spinal injury, multiple sclerosis, diabetic neuropathy, etc.
* Significant connective tissue disorders (e.g., Ehlers-Danlos syndrome).
* Linguistic barriers - not able to give written informed consent in Dutch.
* Severe visual impairment (sufficient to the receipt/comprehension of visual biofeedback).
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jute Richter, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospitals Leuven / KU Leuven
Jan Deprest, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospitals Leuven / KU Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University Hospitals Leuven
Leuven, Vlaams-Braband, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1S49923N
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
S68276
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.